Tempus AI is trading 4.35% up at $79.96 on October 5; no company-specific announcement dated October 5 was found to explain the move.
- The latest listed company news is an October 1 update that 13 abstracts were accepted for a future medical congress.
- A reported market rotation into technology may provide broader context, but available evidence does not directly link it to the stock’s rise.
- The October 2 Personalis merger filing is recent context, not a confirmed explanation.